Healthcare Business

Will Gritstone's COVID-19 Vaccine Be the Best One Yet?
Gritstone pushed higher on Tuesday after the company reported that it was advancing the development of a second-generation vaccine against SARS-CoV-2.
Chris Lange
2 days ago

Is Aclaris Therapeutics a Stock to Buy After Nearly 200% Run-Up and Now This?
Aclaris shares more than doubled to start out the week after the company announced positive results from its mid-stage rheumatoid arthritis study.
Chris Lange
2 days ago

Is Lexicon Pharma a Stock to Buy After 90% Runup and FDA Nod?
Lexicon Pharma shares jumped on Thursday morning after the company announced that it received regulatory feedback from the FDA regarding its heart failure treatment.
Chris Lange
7 days ago

Why United Healthcare Is Paying $13 Billion for a Medtech Firm 
UnitedHealth Group has agreed to pay about $7.8 billion in cash and assume some $5 billion in debt to acquire Change Healthcare, a competing provider of back-office services for health care providers.
Paul Ausick
15 days ago

What Centene Gets for Its $2.2 Billion Magellan Acquisition
Health care provider Centene has struck a deal to acquire Magellan Health in a transaction valued at $2.2 billion. Magellan is a leading provider of behavioral health programs.
Paul Ausick
17 days ago

Why Analysts Lost Confidence in the Arcturus COVID-19 Vaccine
Arcturus Therapeutics shares took a tumble on Tuesday after the company announced update on its COVID-19 vaccine candidate.
Chris Lange
23 days ago

Analysts' Top Health Care Stocks to Buy Could Be Big 2021 Winners
These are five top picks for 2021 from Jefferies for investors looking to add health care stocks to their portfolios. Many across Wall Street feel that the sector will continue to remain strong in...
Lee Jackson
23 days ago
Last Updated: 23 days ago

Is Aprea Therapeutics Doomed?
Aprea Therapeutics stock was absolutely crushed to start out the week after the company announced results from its late-stage trial evaluating the safety and efficacy of its treatment for...
Chris Lange
24 days ago

Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant
Myovant shares shot up on Monday after the company announced a new collaboration with Pfizer for its tumor treatment across a couple of indications.
Chris Lange
24 days ago

How Big Is This Setback to Altimmune's COVID-19 Vaccine Candidate?
Altimmune shares dropped on Thursday after the company announced that it had received an update from the FDA regarding its COVID-19 vaccine candidate.
Chris Lange
28 days ago
Last Updated: 28 days ago

COVID-19: This Is the Most Dangerous County in America
Rates of both confirmed and fatal COVID-19 cases are highly uneven across the nation. The county with the worst rate of fatal cases remains Jerauld County, South Dakota.
Douglas A. McIntyre
30 days ago

Agios Pharma's Big Bet on Anemia
Agios Pharmaceuticals shares jumped on Monday after the company announced that it will be streamlining its portfolio.
Chris Lange
1 month ago

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential
A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to the posted price targets and are best suited for patient, aggressive growth...
Lee Jackson
1 month ago
Last Updated: 30 days ago

Goldman Sachs Has 4 Sizzling Biotech Stocks to Buy That Are Under $10
These four sizzling biotech stocks trading under the $10 level could provide investors with some solid upside potential. They are all Buy rated at Goldman Sachs, one of the top firms on Wall Street.
Lee Jackson
1 month ago

COVID-19: These Are the States Where More Than 1 in 1,000 Have Died
The spread of COVID-19 and the number of fatal cases vary widely from state to state. New Jersey and North Dakota are among those states hit hard.
Douglas A. McIntyre
1 month ago